Subtherapeutic Ocular Penetration of Caspofungin and Associated Treatment Failure in Candida albicans Endophthalmitis
2005; Oxford University Press; Volume: 41; Issue: 3 Linguagem: Inglês
10.1086/431761
ISSN1537-6591
AutoresGuillaume Gauthier, T. Michael Nork, Randall A. Prince, David R. Andes,
Tópico(s)Fungal Infections and Studies
ResumoCandida endophthalmitis represents the most serious ocular complication of candidemia. The pharmacokinetics and pharmacodynamics of fluconazole, amphotericin B, and flucytosine are fairly well established in endophthalmitis therapy. There remains a paucity of clinical data regarding the utility of new antimycotic agents in the treatment of fungal chorioretinitis and endophthalmitis. We report a case of clinical failure of caspofungin in the management of Candida albicans endophthalmitis associated with poor vitreous penetration.
Referência(s)